Autoradiographic distribution and alterations of kinin B2 receptors in the brain and spinal cord of streptozotocin-diabetic rats

Synapse

Volumn 58, Issue 3, 2005, Pages 184-192

  Campos, Maria Martha ^a,d   Ongali, Brice ^a   Thibault, Gaétan ^b   Neugebauer, Witold ^c   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Autoradiography; Brain; Kinin B2 receptors; Spinal cord; Type I diabetes

Indexed keywords

3 (4 HYDROXYPHENYL)PROPIONYLICATIBANT; ACETYLLYSYLBRADYKININ[7 [3 (2 NAPHTHYL)ALANINE] 8 ISOLEUCINE 9 DEARGININE]; ANATIBANT; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; GLUCOSE; ICATIBANT; IODINE 125; RADIOLIGAND; UNCLASSIFIED DRUG; [2 PYRROLIDINECARBOXAMIDE,N [3 [[4 AMINOIMINOMETHYL]BENZOYL]AMINO]PROPYL] 1 [[2,4 DICHLORO 3 [[(2,4 DIMETHYL 8 QUINOLINYL)OXY]METHYL]PHENYL]SULFONYL] 9 CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISSOCIATION CONSTANT; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; KALLIKREIN KININ SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL CORD; STREPTOZOCIN DIABETES;

EID: 26644438096     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20196     Document Type: Article

References (36)

1. 1 receptors in retinal microvessels of the streptozotocin-diabetic rat. Br J Pharmacol 140: 33-40.
2. 1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Review. Br J Pharmacol 143:803-818.
3. 2 receptors in streptozotocin-diabetic rats. Eur J Pharmacol 416:169-177.
4. 1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin. Synapse 57:29-37.
5. Christopher J, Jaffa AA. 2002. Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol 2:1771-1779.
6. 2 kinin receptors by glucose in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 280:H1537-H1546.
7. 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br J Pharmacol 130:375-385.
8. Cloutier F, Ongali B, Campos MM, Thibault G, Neugebauer W, Couture R. 2004. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Br J Pharmacol 142:285-296.
9. Couture R, Girolami JP. 2004. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol 500:467-485.
10. Couture R, Lindsey CJ. 2000. Brain kallikrein-kinin system: from receptors to neuronal pathways and physiological functions. In: Quirion R, Björklund A, Hökfelt T, editors. Peptide receptors, Part I. Amsterdam: Elsevier Science BV. Handbook of Chemical Neuroanatomy, Vol 16. p 241-300.
11. Couture R, Harrisson M, Vianna RM, Cloutier F. 2001. Kinin receptors in pain and inflammation. Eur J Pharmacol 429:161-176.
12. El Midaoui A, Ongali B, Petcu M, Rodi D, de Champlain J, Neugebauer W, Couture R. 2005. Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides 26: 1323-1330.
13. 1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol 457:115-124.
14. 1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides 24:1131-1139.
15. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J, Schölkens BA. 1991. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102:769-773.
16. Koepp J, Caous CA, Rae GA, Balan AC, Lindsey CJ. 2005. Kinin and opioid receptors in the paratrigeminal nucleus modulate the somatosensory reflex to rat sciatic nerve stimulation. Peptides 26: 1339-1345.
17. 1 receptor antagonist. Regul Pept 124:221-224.
18. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. 2005. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77.
19. Lindsey CJ, Buck HS, Fior-Chadi DR, Lapa RCRS. 1997. Pressor effect mediated by bradykinin in the paratrigeminal nucleus of the rat. J Physiol 502(Part 1):119-129.
20. Lopes P, Couture R. 1992. Cardiovascular responses elicited by intrathecal kinins in the conscious rat. Eur J Pharmacol 210:137-147.
21. 8]bradykinin receptor binding sites in the guinea pig spinal cord. Synapse 15: 48-57.
22. 8]bradykinin receptor binding sites in the rat spinal cord: effects of neonatal capsaicin, noradrenergic deafferentation, dorsal rhizotomy and peripheral axotomy. Neuroscience 68:867-881.
23. 1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol 80:328-333.
24. 1 receptors for kinins. Pharmacol Rev 50:357-386.
25. 2 receptors: normal distribution and alterations induced by epilepsy. J Comp Neurol 461:506-519.
26. 1 receptors in the spinal cord of streptozotocin-diabetic rat. NeuroReport 15: 2463-2466.
27. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press.
28. 2 receptor antagonist. Immunopharmacology 43:187-194.
29. Qadri F, Stark E, Häuser W, Jöhren O, Dendorfer A, Dominiak P. 2004. Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats. Int Immunopharmacol 4:571-576.
30. Regoli D, Nsa Allogho S, Rizzi A, Gobeil F, Jr. 1998. Bradykinin receptors and their antagonists. Eur J Pharmacol 348:1-10.
31. Regoli D, Rizzi A, Perron SI, Gobeil F, Jr. 2001. Classification of kinin receptors. Biol Chem 382:31-35.
32. Rodi D, Couture R, Ongali B, Simonato M. 2005. Targeting kinin receptors for the treatment of neurological diseases. Curr Pharm Des 11:1313-1326.
33. 1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can J Physiol Pharmacol 80: 1203-1207.
34. Tschöpe C, Reinecke A, Seidl U, Yu M, Gavriluk V, Riester U, Gohlke P, Graf K, Bader M, Hilgenfeldt U, Pesquero JB, Ritz E, Unger T. 1999. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats. Am J Physiol Heart Circ Physiol 277:H2333-H2340.
35. 1 receptor antagonist. Eur J Pharmacol 205:217-218.
36. Yu YG, Lindsey CJ. 2003. Baroreceptor sensitive neurons in the rat paratrigeminal nucleus. Auton Neurosci 105:25-34.